Pros | Larger AUM within category. Beats FD returns for both 3Y & 5Y duration. | 5Y returns in the top 25% of the category. 3Y returns in the top 25% of the category. Beats FD returns for both 3Y & 5Y duration. | ||
Cons | 3Y returns in the bottom 25% of the category. | - |
INDMoney rank | 6/8 | 1/8 | ||
Category | Equity, Sector - Healthcare | Equity, Sector - Healthcare | ||
Fund Age | 13 Years 4 Months | 13 Years 4 Months | ||
Fund AUM | ₹8306 Cr | ₹4077 Cr | ||
Min Investment |
|
| ||
Expense Ratio | 0.93% | 0.92% | ||
Exit Load | 1% | 0.5% | ||
Benchmark Index | BSE Healthcare TR INR | BSE Healthcare TR INR |
No of Holdings | 39 | 36 | ||
Top 5 Holdings |
|
| ||
No of Sectors | 1 | 3 | ||
Top 3 Sectors | Health (100%) |
| ||
Equity % | 98.97% | 98.55% | ||
Debt % | - | 0.08% | ||
P/E | 35.73 | 46.84 | ||
P/B | 5.7 | 6.78 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | 0.98% | 1.41% | ||
3-Month Return | 0.64% | 1.26% | ||
6-Month Return | -0.08% | -0.97% | ||
1-Year Return | 11.7% | 9.83% | ||
3-Year Return | 25.5% | 27.32% | ||
5-Year Return | 16.61% | 18.26% |
Sharpe | 1.17 | 1.35 | ||
Alpha | 0.22 | 2.77 | ||
Beta | 0.9 | 0.86 | ||
Standard Deviation | 15.21 | 14.35 | ||
Information Ratio | -0.47 | 0.08 |
Description | Nippon India Pharma Fund is an equity fund.The fund could potentially beat inflation in the long-run. | SBI Healthcare Opportunities Fund is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Sailesh Raj Bhan, Kinjal Desai, Divya Sharma, Lokesh Maru | Tanmaya Desai |